Semaglutide Beneficial in Obese Patients With HFpEF
Treatment with the glucagon-like-peptide-1 receptor agonist yielded substantial benefits in patients with heart failure with preserved ejection fraction.
Diagnosis & Disease Information
The Impact of Statins on Prevention of Certain Cancers
Statin use does not have an effect on risk for lung, colorectal, prostate, and breast cancer.
Increased Risk for MACEs Observed After Incident Hospitalization for Acute Gout
Researchers studied the association between hospitalization and major cardiovascular events among patients with acute gout.
Multiple Factors Contribute to Testosterone Decline in Men
Mean testosterone concentration was relatively stable until age 70 years, investigators reported.
ESC: Adverse Outcomes Increased With Suboptimal Adherence to Aspirin After MI
Risk increased for recurrent MI, ischemic stroke, or death with suboptimal adherence through 8 years after MI
Adjustment for Risk Factors Cuts Black-White CVD Mortality Disparity
Hazard ratio for CVD mortality for Blacks versus Whites no longer significant after adjustment for social risk factors
Dapagliflozin Lowers Cardiovascular Risks Despite Worsening Renal Function
Study findings showed a marked elevation in the risks of cardiovascular outcomes in patients with deteriorating kidney function.
Heart, Diabetes, Cancer Drugs on List for Medicare Price Negotiations, White House Says
Enrollees in the Medicare prescription drug program paid a total of $3.4 billion in out-of-pocket costs in 2022 for the 10 initial drugs chosen for price negotiations
Rivaroxaban vs Warfarin for Atrial Fibrillation in CKD Population
Rivaroxaban, a direct oral anticoagulant (DOAC), demonstrated greater efficacy and similar safety compared with warfarin in patients with chronic kidney disease and atrial fibrillation.
Early Lipid-Lowering Therapy May Reduce Risk for Recurrent Cardiovascular Events
In patients hospitalized for ACS, early initiation of inclisiran may decrease risk for recurrent cardiovascular events.
- Loading...
Loading...
Next post in Cardiovascular Disease (CVD)
Loading... 
Loading...